Tilray Brands Inc vs United States Oil ETF — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: United States Oil ETF is far larger — about 3.6× Tilray Brands Inc's market cap, and United States Oil ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and United States Oil ETF for 21 Days on average.
| TLRY | USO | |
|---|---|---|
Market Cap | $530.54M | $1.90B |
Volume | 9,099,075 | 5,932,922 |
Sector | Health | — |
52-Week High | $17.20 | $161.86 |
52-Week Low | $3.54 | $66.17 |
Typical Hold Time | 31 Days | 21 Days |
Enterprise Value | $684.46M | — |
Signals from Pluang's Aura AI — not financial advice
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
USO is trading at $147.58, up 2.55% with a bullish technical signal supported by moving averages. Recent news highlights Middle East tensions affecting oil supply, with OPEC+ maintaining output targets and G-7 planning strategic oil releases. The stock shows strength above key support levels amid volatile energy market conditions.
The outlook remains cautiously optimistic given geopolitical risks and supply constraints. Investment opportunities include potential price appreciation from supply disruptions, while risks involve oil price volatility and regulatory pressures from climate litigation. Institutional sentiment appears mixed with neutral oscillators suggesting near-term consolidation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →